Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 341-348

  Nakayama, Masafumi ^a   Ishidoh, Kazumi ^a   Kojima, Yuko ^a   Harada, Norihiro ^a   Kominami, Eiki ^a   Okumura, Ko ^a   Yagita, Hideo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; CATHEPSIN B; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROTEIN TWEAK; REACTIVE OXYGEN METABOLITE; RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0037223197     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.341     Document Type: Article

References (35)

1. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
2. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104:487.
3. Chicheportiche, Y., P. R. Bourdon, H. Xu, Y. M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:32401.
4. Schneider, P., R. Schwenzer, E. Haas, F. Muhlenbeck, G. Schubert, P. Scheurich, J. Tschopp, and H. Wajant. 1999. TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur. J. Immunol. 29:1785.
5. Lynch, C. N., Y. C. Wang, J. K. Lund, Y. W. Chen, J. A. Leal, and S. R. Wiley. 1999. TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 274:8455.
6. Nakayama, M., N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita. 2000. Involvement of TWEAK in interferon-γ-stimulated monocyte cytotoxicity. J. Exp. Med. 192:1373.
7. Nakayama, M., K. Ishidoh, N. Kayagaki, Y. Kojima, N. Yamaguchi, H. Nakano, E. Kominami, K. Okumura, and H. Yagita. 2002. Multiple pathways of TWEAK-induced cell death. J. Immunol. 168:734.
8. Grell, M., G. Zimmermann, E. Gottfried, C. M. Chen, U. Grunwald, D. C. Huang, Y. H. Wu Lee, H. Durkop, H. Engelmann, P. Scheurich, et al. 1999. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:3034.
9. Eliopoulos, A. G., C. Davies, P. G. Knox, N. J. Gallagher, S. C. Afford, D. H. Adams, and L. S. Young. 2000. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol. Cell. Biol. 20:5503.
10. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990.
11. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, et al. 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79.
12. Marsters, S. A., J. P. Sheridan, R. M. Pitti, J. Brush, A. Goddard, and A. Ashkenazi. 1998. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8:525.
13. Wiley, S. R., L. Cassiano, T. Lofton, T. Davis-Smith, J. A. Winkles, V. Lindner, H. Liu, T. O. Daniel, C. A. Smith, and W. C. Fanslow. 2001. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837.
14. Feng, S. L., Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles. 2000. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am. J. Pathol. 156:1253.
15. Meighan-Mantha, R. L., D. K. Hsu, Y. Guo, S. A. Brown, S. L. Feng, K. A. Peifley, G. F. Alberts, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, et al. 1999. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274:33166.
16. Muno, D., N. Sutoh, T. Watanabe, Y. Uchiyama, and E. Kominami. 1990. Effect of metabolic alterations on the density and the contents of cathepsins B, H and L of lysosomes in rat macrophages. Eur. J. Biochem. 191:91.
17. Tada, K., T. Okazaki, S. Sakon, T. Kobarai, K. Kurosawa, S. Yamaoka, H. Hashimoto, T. W. Mak, H. Yagita, K. Okumura, et al. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276:36530.
18. + T cell-mediated cytotoxicity. J. Immunol. 162:2639.
19. Reik, L. M., S. L. Maines, D. E. Ryan, W. Levin, S. Bandiera, and P. E. Thomas. 1987. A simple, non-chromatographic purification procedure for monoclonal antibodies: Isolation of monoclonal antibodies against cytochrome P450 isozymes. J. Immunol. Methods 100:123.
20. Vercammen, D., R. Beyaert, G. Denecker, V. Goossens, G. Van Loo, W. Declercq, J. Grooten, W. Fiers, and P. Vandenabeele. 1998. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187:1477.
21. Vercammen, D., G. Brouckaert, G. Denecker, M. Van de Craen, W. Declercq, W. Fiers, and P. Vandenabeele. 1998. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:919.
22. Khwaja, A., and L. Tatton. 1999. Resistance to the cytotoxic effects of tumor necrosis factor α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274:36817.
23. Buttle, D. J., M. Murata, C. G. Knight, and A. J. Barrett. 1992. CA074 methyl ester: A proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299:377.
24. Zhao, M., J. W. Eaton, and U. T. Brunk. 2000. Protection against oxidant-mediated lysosomal rupture: A new anti-apoptotic activity of Bcl-2? FEBS Lett. 485:104.
25. Yuan, X. M., W. Li, H. Dalen, J. Lotem, R. Kama, L. Sachs, and U. T. Brunk. 2002. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. USA 99:6286.
26. Fiers, W., R. Beyaert, W. Declercq, and P. Vandenabeele. 1999. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 18:7719.
27. Gray, J., M. M. Haran, K. Schneider, S. Vesce, A. M. Ray, D. Owen, I. R. White, P. Cutler, and J. B. Davis. 2001. Evidence that inhibition of cathepsin-B contributes to the neuroprotective properties of caspase inhibitor Tyr-Val-Ala-Aspchloromethyl ketone. J. Biol. Chem. 276:32750.
28. Zang, Y., R. L. Beard, R. A. Chandraratna, and J. X. Kang. 2001. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ. 8:477.
29. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
30. Alderson, M. R., T. W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R. E. Miller, and D. H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1799.
31. Chuntharapai, A., K. Dodge, K. Grimmer, K. Schroeder, S. A. Masters, H. Koeppen, A. Ashkenazi, and K. J. Kim. 2001. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J. Immunol. 166:4891.
32. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immun. 3:221.
33. Pimentel-Muinos, F. X., and B. Seed. 1999. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 11:783.
34. Holler, N., R. Zaru, O. Micheau, M. Thome, A. Attinger, S. Valitutti, J. L. Bodmer, P. Schneider, B. Seed, and J. Tschopp. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immun. 1:489.
35. Lin, Y., A. Devin, Y. Rodriguez, and Z. G. Liu. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13:2514.